| OAB0605 | Weight changes after switching to doravirine/lamivudine/TDF in the DRIVE-SHIFT trial | Oral abstract session with live Q&A | B22 |
| PEB0199 | Weight change before and after switching therapy to tenofovir alafenamide (TAF) in virologically suppressed (VS) persons | E-poster | B22 |
| PEB0233 | Weight change among treatment naive women initiating dolutegravir in the ARIA study | E-poster | B30 |
| PED1176 | We are all women: Barriers and facilitators to inclusion of transgender women in HIV treatment and support services designed for cisgender women | E-poster | D46 |
| PEF1840 | War on drugs: Opportunities in accessing to harm reduction services for people who use drugs in Mombasa County | E-poster | F40 |
| PED1016 | Walking a fine line: Understanding the overlap of sex work and young women in South Africa | E-poster | D34 |
| PEC0747 | Walk the talk: Engaging community in the HIV research agenda | E-poster | C52 |
| LBPEA03 | Vpu inhibitor BIT225 alters T cell activation and homing plasma membrane receptor expression on CD4+T cells (CD28 and CCR7) and monocyte-derived macrophages (CD80 and CD86) | E-poster | A22 |
| PEE1504 | Virtual Intervention for HIV prevention among MSM - an online to Offline HIV Service Delivery model for MSM in Delhi, India | E-poster | E31 |
| PEB0337 | Virological outcome among vertically HIV infected patients transferred from pediatric care to adult units in Madrid | E-poster | B61 |